Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2023-10-23 00:00:00 ET · period of report 2023-10-23 · accession 0001610717-23-000313 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-10-23 | 2023-10-23 | RVMD | Anders Jack | CFO | M - OptEx | $2.98 | +24.5K | 73.1K | +51% | +$73.0K |
| DM | 2023-10-23 | 2023-10-23 | RVMD | Anders Jack | CFO | M - OptEx | $0.00 | -24.5K | 22.8K | -52% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-23 | M | A | 5,137 | $4.09 | 78,191 | D | — | — | (F1) Includes 40,800 restricted stock units. |
| 2 | Common | Common Stock | 2023-10-23 | M | A | 19,387 | $2.68 | 73,054 | D | — | — | (F1) Includes 40,800 restricted stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-10-23 | M | D | 5,137 | $0.00 | 0 | D | $4.09 · 2023-03-13 to 2029-03-12 | 5,137 Common Stock | |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-10-23 | M | D | 19,387 | $0.00 | 22,814 | D | $2.68 · 2022-08-16 to 2028-09-26 | 19,387 Common Stock |